Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 131Lymphoma 117Lymphoma, Large B-Cell, Diffuse 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Multiple Myeloma 50Lymphoma, Non-Hodgkin 46Lymphoma, Follicular 45Leukemia 39Hodgkin Disease 33Lymphoma, Mantle-Cell 32Burkitt Lymphoma 32Lymphoma, Large-Cell, Immunoblastic 21Lymphoma, Large-Cell, Anaplastic 20Lymphoma, B-Cell, Marginal Zone 19Neoplasm Metastasis 16Leukemia, Lymphocytic, Chronic, B-Cell 16Neoplasms, Plasma Cell 15Neoplasms 13Lymphoma, T-Cell, Peripheral 10Dendritic Cell Sarcoma, Interdigitating 10Recurrence 9Lymphoma, B-Cell 9Primary Myelofibrosis 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Immunoblastic Lymphadenopathy 8Blast Crisis 7Lymphoma, T-Cell 6Graft vs Host Disease 6Waldenstrom Macroglobulinemia 5Prostate Cancer Metastatic 5

Interventions

Gefitinib 3Erlotinib Hydrochloride 3sotorasib 1pralsetinib 1osimertinib 1ficlatuzumab 1exemestane 1entinostat 1durvalumab 1cobimetinib 1camrelizumab 1Tyrosine Kinase Inhibitors 1Radiosurgery 1Prednisone 1Pemetrexed 1Leuprolide 1Dasatinib 1Carboplatin 1Afatinib 1AZD3759 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Respiratory Tract Diseases × Prednisone × Clear all
NCT00004436 2015-03-25

Randomized Study of Hormonal Regulation of Infantile Hemangioma

FDA Office of Orphan Products Development

Phase NA Completed
30 enrolled

Hemangioma, Respiratory Tract Diseases, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡